Supplemental Figures. Kumavath et al. Bioinformation ...

Supplemental Figures. Kumavath et al. Bioinformation 12(6): 324-331 (2016)

Figure 1: Molecular interaction of natural substrate Androstenedione (ASD) with CYP19A1 protein.


Figure 2 A: Close view of Rhodethrin with CYP19A1.

Figure 2 B: Binding mode of Rhodethrin with CYP19A1.


Figure 2 C: Docked conformation of Rhodethrin in the ligand binding region of CYP19A1.

Figure 3 A: Close view of Rubrivivaxin with CYP19A1.


Figure 3 B: Binding mode of Rubrivivaxin with CYP19A1.

Figure 3 C: Docked conformation of Rubrivivaxin in the ligand binding region of CYP19A1.


Figure 4 A: Close view of Troglitazone with CYP19A1.

Figure 4 B: Binding mode of Troglitazone CYP19A1.


Figure 4 C: Docked conformation of Troglitazone in the ligand binding region of CYP19A1.

Figure 5 A: Close view of Toremifene with CYP19A1.


Figure 5 B: Binding mode of Toremifene CYP19A1.

Figure 5 C: Docked conformation of Toremifene in the ligand binding region of CYP19A1.


Figure 6 A: Close view of Testolactone with CYP19A1.

Figure 6 B: Binding mode of Testolactone CYP19A1.


Figure 6 C: Docked conformation of Testolactone in the ligand binding region of CYP19A1.

Figure 7 A: Close view of Danazol with CYP19A1.


Figure 7 B: Binding mode of Danazol CYP19A1.

Figure 7 C: Docked conformation of Danazol in the ligand binding region of CYP19A1.